國際簡稱:GLOB HEART 參考譯名:全球心臟
主要研究方向:Medicine-Cardiology and Cardiovascular Medicine 非預警期刊 審稿周期: 5 Weeks
《全球心臟》(Global Heart)是一本由Elsevier Science & Technology出版的以Medicine-Cardiology and Cardiovascular Medicine為研究特色的國際期刊,發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章,及時報道該領(lǐng)域相關(guān)理論、實踐和應用學科的最新發(fā)現(xiàn),旨在促進該學科領(lǐng)域科學信息的快速交流。該期刊是一本未開放期刊,近三年沒有被列入預警名單。
Global Heart offers a forum for dialogue and education on research, developments, trends, solutions and public health programs related to the prevention and control of cardiovascular diseases (CVDs) worldwide, with a special focus on low- and middle-income countries (LMICs). Manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent CVDs and the underlying factors. The emphasis should be on approaches applicable in settings with limited resources.
Economic evaluations of successful interventions are particularly welcome. We will also consider negative findings if important. While reports of hospital or clinic-based treatments are not excluded, particularly if they have broad implications for cost-effective disease control or prevention, we give priority to papers addressing community-based activities. We encourage submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations related to prevention.
Global Heart is particularly interested in publishing data from updated national or regional demographic health surveys, World Health Organization or Global Burden of Disease data, large clinical disease databases or registries. Systematic reviews or meta-analyses on globally relevant topics are welcome. We will also consider clinical research that has special relevance to LMICs, e.g. using validated instruments to assess health-related quality-of-life in patients from LMICs, innovative diagnostic-therapeutic applications, real-world effectiveness clinical trials, research methods (innovative methodologic papers, with emphasis on low-cost research methods or novel application of methods in low resource settings), and papers pertaining to cardiovascular health promotion and policy (quantitative evaluation of health programs.
CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||||||||||
5.7 | 1.022 | 1.021 |
|
名詞解釋:CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù),是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據(jù)是期刊最近4年(含計算年度)的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如,2022年的 CiteScore 計算方法為:2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量 注:文獻類型包括:文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫(yī)學 | 3區(qū) | CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng) | 3區(qū) |
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫(yī)學 | 4區(qū) | CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng) | 4區(qū) |
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫(yī)學 | 4區(qū) | CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng) | 4區(qū) |
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫(yī)學 | 3區(qū) | CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng) | 3區(qū) |
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫(yī)學 | 4區(qū) | CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng) | 4區(qū) |
Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
否 | 否 | 醫(yī)學 | 3區(qū) | CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng) | 3區(qū) |
按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學科:CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | 72 / 220 |
67.5% |
按JCI指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學科:CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | 73 / 220 |
67.05% |
Frontiers In Public Health
中科院 3區(qū) JCR Q2
Frontiers In Pharmacology
中科院 2區(qū) JCR Q1
Biomedicine & Pharmacotherapy
中科院 2區(qū) JCR Q1
Discover Oncology
中科院 4區(qū) JCR Q2
Bmc Psychiatry
中科院 2區(qū) JCR Q2
Bmc Neurology
中科院 3區(qū) JCR Q3
Journal Of Materials Chemistry B
中科院 3區(qū) JCR Q1
Medcomm
中科院 3區(qū) JCR Q1
若用戶需要出版服務,請聯(lián)系出版商:2N, 6 OSBORNE ST, LONDON, ENGLAND, E1 6TD。